Remote Monitoring and Optimization of Heart Failure Therapy

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 800 participants.

Also called NCT07622472

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 800 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07622472
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
France, Germany, Italy, Netherlands, Poland, Spain, Sweden, Switzerland, United Kingdom (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07622472. Randomized; no masking; primary purpose treatment. Start 2026-10-01 (anticipated); primary completion 2028-08-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Remote Monitoring and Optimization of Heart Failure Therapy
Acronym
REMODEL-HF
Condition
Heart Failure
Intervention (Device)
Wearable Monitoring Device for Heart Failure
Lead sponsor
Zoll Medical Corporation (class: industry)

Record details

Record id
cardio:ct-nct07622472
Content hash
50087bec49178259600dd3d7d19084eed6034049cfb972d09d82eb888ef8ebd6